RISUG. The Single dose, Safe, Reversible Contraceptive Method for Men

RISUG. The Single dose, Safe, Reversible Contraceptive Method for Men

RISUG. The Single dose, Safe, Reversible Contraceptive Method for Men

Bye-bye Vasectomies (and if women can have it their way, bye-bye oral contraceptive pills too) !

This wonder drug, which has been developed at the Indian Institute of Technology in Kharagpur, India, promises to be a much safer, easier and reversible contraceptive method for men, and has garnered widespread global interest.

As opposed to a vasectomy, which involves cutting the vas deferens, the RISUG (Reversible Inhibition of Sperm Under Guidance), acts through the injection of a polymer gel into the vas deferens, which then coats the inside walls of the vas deferens and chemically incapacitates released sperm, rendering them incapable of fertilizing any eggs.

Currently under advanced trials in India, where some men have used it successfully for over 15 years, RISUG offers results which are similar to a traditional vasectomy but with added advantages of the process being simple, relatively pain free and easily reversible.

Men who wish to reverse the procedure and restore fertility at any point after choosing this contraceptive method, can do so easily with the polymer being able to get flushed out of the system with another injection.

Biggest Contraceptive Revolution since the Condom?

Professor Sujoy Guha, Inventor of RISUG

Professor Sujoy Guha, Inventor of RISUG

Developed by an Indian scientist called Sujoy Guha, the RISUG concept has been developed and refined for over 30 years.

Through the trials carried out by Guha’s team across hundreds of men, RISUG was found to be 100% effective, with no failures or serious adverse reactions reported by any of the subjects. The procedure now being in late Phase III clinical trials in India means that usage of this drug could be approved in India in as little as two years.

The RISUG drug is simple to administer and inexpensive to manufacture, offering the developing world a cost effective solution towards avoiding unwanted pregnancies.

For the west, this contraceptive method offers a safer option for women when compared with the risks associated with the long-term use of birth-control pills, while also allowing men the option of not having to deal with the hassle of condoms or a vasectomy.

According to Ronald Weiss, a leading Canadian vasectomy surgeon and a member of the World Health Organization, the RISUG “holds tremendous promise”

“If we can prove that RISUG is safe and effective and reversible, there is no reason why anybody would have a vasectomy,” he said in a statement.

And while the RISUG does not protect the user against the spread of STDs, the belief is that the styrene maleic acid may reduce pH to a level capable of destroying HIV in semen. The drug is currently being studied to test its effectiveness as an anti-HIV agent.

Pharmaceutical Companies not so Keen

With the RISUG being a single-dose inexpensive drug – some estimates say that the syringe could end up costing more than the material it injects – pharma companies until now have not been too keen towards being corporate partners in facilitating the development of this drug.

Oral contraceptive pills need to be used everyday often for a long period of time, and constitute a more lucrative business as opposed to the easily affordable, one-time-use RISUG.

However, recently a small American foundation called Parsemus has purchased the rights to begin RISUG (Vasagel) clinical trials in the U.S starting next year. Parsemus hopes to launch the product in the U.S market by 2015.

Richard Meryn
Richard Meryn, Associate Editor Industry Leaders Magazine (www.industryleadersmagazine.com)

Recent Posts

Strong iPhone 12 sales could boost Apple’s Q3 2021 earnings

Strong iPhone 12 sales could boost Apple’s Q3 2021 earnings

Will Apple manage to post solid earnings in Q3 2021? Here’s what Wall Street’s top analysts have to say ahead of Apple’s Q3 2021 earnings report today.
17 hours ago
Tesla earnings top $1 billion for the first time

Tesla earnings top $1 billion for the first time

Tesla earnings not only blew past analyst expectations but also marked the first time the automaker’s quarterly profit joined the three-comma club.
19 hours ago
Elon Musk tweet pushes Dogecoin prices up again

Elon Musk tweet pushes Dogecoin prices up again

Dogecoin was launched as a joke in 2013. The cryptocurrency is up a staggering 6,000% compared to last year’s prices due to wild speculations.
20 hours ago
Amazon to hire a crypto lead, may soon accept payments in cryptocurrency

Amazon to hire a crypto lead, may soon accept payments in cryptocurrency

The product lead will develop the full marketing strategy from customer experience to technical development to launching it.
2 days ago
Billionaire CEO Elon Musk Shares the Brutal Truth about Life as an Entrepreneur

Billionaire CEO Elon Musk Shares the Brutal Truth about Life as an Entrepreneur

“I would say I’ve had some pretty tough life experiences and Tesla’s probably responsible for two-thirds of all personal and professional pain combined, to give you a sense o
3 days ago
AT&T, Airbnb & UPS among firms to face Akamai’s global outage

AT&T, Airbnb & UPS among firms to face Akamai’s global outage

Global outage causes Akamai Technologies to re-think cyber securities.
5 days ago